{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:12:39Z","timestamp":1778602359924,"version":"3.51.4"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"abstract":"<jats:p>Previous studies have suggested a link between viral infections and myocarditis, but the causal nature of this relationship remains unclear. The antibody-mediated immune responses generated after such infections reflect an individual\u2019s infection history and immune status, offering insights into disease mechanisms and potential therapeutic targets. We used 46 antibody-mediated immune responses as exposures, with European myocarditis and Finnish nonischemic cardiomyopathy as outcomes. The overlapping results were then identified and further validated using Mendelian randomization based on generalized summary data to ensure accuracy. Our Mendelian randomization based on generalized summary data analysis showed that Epstein\u2013Barr virus-related antibody levels, including EBNA-1 (OR\u2005=\u20051.7225, 95% CI: 1.2692\u20132.3376, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001) and VCA p18 (OR\u2005=\u20051.8108, 95% CI: 1.1919\u20132.7511, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0054), were significantly associated with an increased risk of myocarditis. In addition, polyomavirus-related antibody levels, including anti-polyomavirus 2 IgG seropositivity (OR\u2005=\u20050.5762, 95% CI: 0.4521\u20130.7344, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), anti-Merkel cell polyomavirus IgG seropositivity (OR\u2005=\u20050.6924, 95% CI: 0.5522\u20130.8682, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0014), and Merkel cell polyomavirus VP1 antibody levels (OR\u2005=\u20050.6093, 95% CI: 0.3989\u20130.9307, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0219), were significantly associated with a reduced risk of myocarditis. Similarly, antibody levels against varicella zoster virus glycoproteins E and I were also inversely associated with myocarditis risk (OR\u2005=\u20050.4478, 95% CI: 0.3035\u20130.6606, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). We identified 6 antibody-mediated immune responses associated with myocarditis, along with multiple genetic variants linked to these responses. These findings may help prioritize future research directions and guide drug development.<\/jats:p>","DOI":"10.1097\/md.0000000000042496","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:01:54Z","timestamp":1753156914000},"page":"e42496","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Causal effects of antibody-mediated immune responses on myocarditis: A two-sample Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Jizhang","family":"Sheng","sequence":"first","affiliation":[{"name":"Department of Cardiology, Yantai Yeda Hospital, Yantai, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Ningxia Medical University, Ningxia, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lintao","family":"Dong","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Ningxia Medical University, Ningxia, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-7375","authenticated-orcid":false,"given":"Jinpeng","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yantai Yeda Hospital, Yantai, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250722","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/heartjnl-2014-306363","article-title":"Clinical presentation and diagnosis of myocarditis.","volume":"101","author":"Caforio","year":"2015","journal-title":"Heart"},{"key":"R2-20250722","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jacc.2020.01.036","article-title":"Ventricular arrhythmias in myocarditis: characterization and relationships with myocardial inflammation.","volume":"75","author":"Peretto","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250722","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.056817","article-title":"Prevalence, characteristics, and outcomes of COVID-19-associated acute myocarditis.","volume":"145","author":"Ammirati","year":"2022","journal-title":"Circulation"},{"key":"R4-20250722","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/hc3401.095198","article-title":"Advances in the understanding of myocarditis.","volume":"104","author":"Liu","year":"2001","journal-title":"Circulation"},{"key":"R5-20250722","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/vim.2006.19.133","article-title":"Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.","volume":"19","author":"Tam","year":"2006","journal-title":"Viral Immunol"},{"key":"R6-20250722","doi-asserted-by":"crossref","first-page":"1188330","DOI":"10.3389\/fimmu.2023.1188330","article-title":"Cardiovascular involvement in Epstein-Barr virus infection.","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"R7-20250722","doi-asserted-by":"crossref","first-page":"1030440","DOI":"10.3389\/fmicb.2022.1030440","article-title":"Persistent viral infections and their role in heart disease.","volume":"13","author":"Badrinath","year":"2022","journal-title":"Front Microbiol"},{"key":"R8-20250722","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular mimicry as a mechanism of autoimmune disease.","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"R9-20250722","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.aao4572","article-title":"Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.","volume":"359","author":"Chowell","year":"2018","journal-title":"Science"},{"key":"R10-20250722","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-3-030-17864-2_3","article-title":"HLA Class-I expression and cancer immunotherapy.","volume":"1151","author":"Garrido","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"R11-20250722","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization.","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"R12-20250722","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2018.4175","article-title":"Assessment of bidirectional relationships between physical activity and depression among adults: a 2-sample Mendelian randomization study.","volume":"76","author":"Choi","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"R13-20250722","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ije\/dyz176","article-title":"Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study.","volume":"48","author":"Lin","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R14-20250722","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12916-024-03607-5","article-title":"Addressing the credibility crisis in Mendelian randomization.","volume":"22","author":"Burgess","year":"2024","journal-title":"BMC Med"},{"key":"R15-20250722","doi-asserted-by":"crossref","first-page":"ofaa450","DOI":"10.1093\/ofid\/ofaa450","article-title":"Genetic determinants of antibody-mediated immune responses to infectious diseases agents: a genome-wide and HLA association study.","volume":"7","author":"Butler-Laporte","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R16-20250722","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"Finngen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R17-20250722","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","article-title":"Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies.","volume":"50","author":"Zhou","year":"2018","journal-title":"Nat Genet"},{"key":"R18-20250722","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/s41467-022-33675-1","article-title":"Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke.","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"R19-20250722","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors.","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"R21-20250722","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-017-02317-2","article-title":"Causal associations between risk factors and common diseases inferred from GWAS summary data.","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat Commun"},{"key":"R22-20250722","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases.","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"R23-20250722","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R24-20250722","doi-asserted-by":"crossref","first-page":"908790","DOI":"10.3389\/fcell.2022.908790","article-title":"Macrophage, a potential targeted therapeutic immune cell for cardiomyopathy.","volume":"10","author":"Chen","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R25-20250722","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2011.09.074","article-title":"Update on myocarditis.","volume":"59","author":"Kindermann","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R26-20250722","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.CIR.99.8.1091","article-title":"From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.","volume":"99","author":"Kawai","year":"1999","journal-title":"Circulation"},{"key":"R27-20250722","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10741-018-9724-x","article-title":"Diagnostic and prognostic role of cardiac magnetic resonance in acute myocarditis.","volume":"24","author":"Grigoratos","year":"2019","journal-title":"Heart Fail Rev"},{"key":"R28-20250722","doi-asserted-by":"crossref","first-page":"826283","DOI":"10.3389\/fcvm.2022.826283","article-title":"Cardiac MR: from theory to practice.","volume":"9","author":"Ismail","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R29-20250722","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection.","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"key":"R30-20250722","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cardiores.2007.06.025","article-title":"Myocarditis in newborn wild-type BALB\/c mice infected with the murine gamma herpesvirus MHV-68.","volume":"76","author":"Hausler","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R31-20250722","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R32-20250722","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1203\/00006450-200101000-00017","article-title":"Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions.","volume":"49","author":"Hamamichi","year":"2001","journal-title":"Pediatr Res"},{"key":"R33-20250722","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2249.2007.03584.x","article-title":"Adhesion of Epstein-Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines.","volume":"151","author":"Kanno","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"R34-20250722","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4049\/jimmunol.182.2.851","article-title":"The EBV-encoded dUTPase activates NF-Kappa B through the TLR2 and MyD88-dependent signaling pathway.","volume":"182","author":"Ariza","year":"2009","journal-title":"J Immunol"},{"key":"R35-20250722","doi-asserted-by":"crossref","first-page":"e13582","DOI":"10.1097\/MD.0000000000013582","article-title":"Myocardial calcification found in Epstein\u2013Barr viral myocarditis and rhabdomyolysis: a case report.","volume":"97","author":"Sui","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R36-20250722","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-021-01689-5","article-title":"Clinical analysis of chronic active EBV infection with coronary artery dilatation and a matched case-control study.","volume":"16","author":"Wei","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R37-20250722","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ehf2.12611","article-title":"Infarct-like myocarditis with coronary vasculitis and aneurysm formation caused by Epstein\u2013Barr virus infection.","volume":"7","author":"Chimenti","year":"2020","journal-title":"ESC Heart Fail"},{"key":"R38-20250722","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection.","volume":"187","author":"Kimura","year":"2003","journal-title":"J Infect Dis"},{"key":"R39-20250722","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3760\/cma.j.issn.0366-6999.2009.03.005","article-title":"Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases.","volume":"122","author":"Lu","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"R40-20250722","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective.","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"R41-20250722","first-page":"288","article-title":"Varicella myopericarditis mimicking myocardial infarction in a 17-year-old boy.","volume":"38","author":"De","year":"2011","journal-title":"Tex Heart Inst J"},{"key":"R42-20250722","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00246-009-9637-5","article-title":"Myopericarditis associated with varicella zoster virus infection.","volume":"31","author":"Kao","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"R43-20250722","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/S1047951101001019","article-title":"Cardiac complications in children following infection with varicella zoster virus.","volume":"11","author":"Abrams","year":"2001","journal-title":"Cardiol Young"},{"key":"R44-20250722","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/emj.2006.034280","article-title":"Varicella zoster induced cardiac dysfunction: a case report.","volume":"24","author":"Dennison","year":"2007","journal-title":"Emerg Med J"},{"key":"R45-20250722","first-page":"e284","article-title":"Acute myocarditis following varicella zoster infection in an immunocompetent adolescent: an uncommon complication.","volume":"118","author":"Azak","year":"2020","journal-title":"Arch Argent Pediatr"},{"key":"R46-20250722","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10915810591000659","article-title":"Universal varicella vaccination: efficacy trends and effect on herpes zoster.","volume":"24","author":"Goldman","year":"2005","journal-title":"Int J Toxicol"},{"key":"R47-20250722","first-page":"1017686","article-title":"Ventricular fibrillation following varicella zoster myocarditis.","volume":"2017","author":"Ioannou","year":"2017","journal-title":"Case Rep Cardiol"},{"issue":"Suppl 2","key":"R48-20250722","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1016\/j.ihj.2015.08.026","article-title":"Varicella myopericarditis mimicking acute myocardial infarction with ARDS - a rare association in an immunocompetent young adult.","volume":"68 Suppl 2","author":"Chaudhari","year":"2016","journal-title":"Indian Heart J"},{"key":"R49-20250722","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma.","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"R50-20250722","first-page":"2601","article-title":"Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.","volume":"25","author":"Tegerstedt","year":"2005","journal-title":"Anticancer Res"},{"key":"R51-20250722","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1517\/14712598.7.7.997","article-title":"Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer.","volume":"7","author":"Ramqvist","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"R52-20250722","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1158\/0008-5472.CAN-05-0335","article-title":"A single vaccination with polyomavirus VP1\/VP2Her2 virus-like particles prevents outgrowth of HER-2\/neu-expressing tumors.","volume":"65","author":"Tegerstedt","year":"2005","journal-title":"Cancer Res"},{"key":"R53-20250722","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.1128\/JVI.74.24.11963-11965.2000","article-title":"Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus.","volume":"74","author":"Heidari","year":"2000","journal-title":"J Virol"},{"key":"R54-20250722","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/1389201043376670","article-title":"SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy.","volume":"5","author":"Kimchi-Sarfaty","year":"2004","journal-title":"Curr Pharm Biotechnol"},{"key":"R55-20250722","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0264-410X(01)00506-0","article-title":"Immunization of T-cell deficient mice against polyomavirus infection using viral pseudocapsids or temperature sensitive mutants.","volume":"20","author":"Heidari","year":"2002","journal-title":"Vaccine"},{"key":"R56-20250722","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jmv.10394","article-title":"VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.","volume":"70","author":"Vlastos","year":"2003","journal-title":"J Med Virol"},{"key":"R57-20250722","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2165\/10898580-000000000-00000","article-title":"Human papillomavirus vaccines: current status and future prospects.","volume":"70","author":"Garland","year":"2010","journal-title":"Drugs"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:02:01Z","timestamp":1753156921000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":57,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042496","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"2025-02-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}